- Catalent Pharma Solutions (St. Petersburg, FL)
- …patients annually. St. Petersburg is our primary softgel development and manufacturing facility in North America with a capacity of 18 billion capsules per year. ... Scherer softgel technology is a proven oral drug delivery solution to enhance bioavailability of poorly soluble Rx and...support the forecasted demand as predicted by Catalent Pharma Solutions . Rotating 12 hour shifts 7pm-7am Catalent is committed… more
- Catalent Pharma Solutions (St. Petersburg, FL)
- …patients annually. St. Petersburg is our primary softgel development and manufacturing facility in North America with a capacity of 18 billion capsules per year. ... The featured RP Scherer softgel technology is a proven oral drug delivery solution to enhance bioavailability of poorly soluble Rx and OTC drug candidates.… more
- Catalent Pharma Solutions (St. Petersburg, FL)
- …patients annually. St. Petersburg is our primary softgel development and manufacturing facility in North America with a capacity of 18 billion capsules per year. ... The featured RP Scherer softgel technology is a proven oral drug delivery solution to enhance bioavailability of poorly soluble Rx and OTC drug candidates.… more
- Catalent Pharma Solutions (St. Petersburg, FL)
- …patients annually. St. Petersburg is our primary softgel development and manufacturing facility in North America with a capacity of 18 billion capsules per year. ... The featured RP Scherer softgel technology is a proven oral drug delivery solution to enhance bioavailability of poorly soluble Rx and OTC drug candidates.… more
- Catalent Pharma Solutions (St. Petersburg, FL)
- …patients annually. St. Petersburg is our primary softgel development and manufacturing facility in North America with a capacity of 18 billion capsules per year. ... The featured RP Scherer softgel technology is a proven oral drug delivery solution to enhance bioavailability of poorly soluble Rx and OTC drug candidates.… more
- Catalent Pharma Solutions (St. Petersburg, FL)
- …patients annually. St. Petersburg is our primary softgel development and manufacturing facility in North America with a capacity of 18 billion capsules per year. ... The featured RP Scherer softgel technology is a proven oral drug delivery solution to enhance bioavailability of poorly soluble Rx and OTC drug candidates.… more
- Catalent Pharma Solutions (St. Petersburg, FL)
- …patients annually. St. Petersburg is our primary softgel development and manufacturing facility in North America with a capacity of 18 billion capsules per year. ... The featured RP Scherer softgel technology is a proven oral drug delivery solution to enhance bioavailability of poorly soluble Rx and OTC drug candidates.… more
- Catalent Pharma Solutions (St. Petersburg, FL)
- …patients annually. St. Petersburg is our primary softgel development and manufacturing facility in North America with a capacity of 18 billion capsules per year. ... The featured RP Scherer softgel technology is a proven oral drug delivery solution to enhance bioavailability of poorly soluble Rx and OTC drug candidates.… more
- Catalent Pharma Solutions (St. Petersburg, FL)
- …Catalent's St. Petersburg is our primary softgel development and manufacturing facility in North America with a capacity of 18 billion capsules per year. ... The featured RP Scherer softgel technology is a proven oral drug delivery solution to enhance bioavailability of poorly soluble Rx and OTC drug candidates.… more
- Catalent Pharma Solutions (St. Petersburg, FL)
- …patients annually. St. Petersburg is our primary softgel development and manufacturing facility in North America with a capacity of 18 billion capsules per year. ... The featured RP Scherer softgel technology is a proven oral drug delivery solution to enhance bioavailability of poorly soluble Rx and OTC drug candidates.… more